Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Occupational and Environmental Medicine|October 26, 2019
Barriers and Solutions to the Inclusion of Broader Benefits in Biopharmaceutical Value AssessmentsDavid Wamble, Mike Ciarametaro, Robert Dubois
Journal of Managed Care & Specialty Pharmacy|June 22, 2018
The Effect of Medical Technology Innovations on Patient Outcomes, 1990-2015: Results of a Physician SurveyDavid E Wamble, Michael Ciarametaro, Robert Dubois
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
The Dollar or Disease Burden: Caps on Healthcare Spending May Save Money, but at What "Cost" to Patients?Michael Ciarametaro, Katherine Houghton, David Wamble, et al.
Journal of Managed Care & Specialty Pharmacy|February 26, 2014
The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and cautionNancy A Dreyer, Priscilla Velentgas, Kimberly Westrich, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 15, 2005
Economic burden of patients with anemia in selected diseasesWilliam B Ershler, Kristina Chen, Eileen B Reyes, et al.
The American Journal of Managed Care|December 21, 2017
Insurance switching and mismatch between the costs and benefits of new technologiesDavid Cutler, Michael Ciarametaro, Genia Long, et al.
The American Journal of Managed Care|January 23, 2016
Care pathways in US healthcare settings: current successes and limitations, and future challengesAnita Chawla, Kimberly Westrich, Susanna Matter, et al.
Psychotherapy (Chicago, Ill.)|November 30, 2011
Clients' experiences giving gifts to therapistsSarah Knox, Robert Dubois, Jacquelyn Smith, et al.
Journal of Managed Care & Specialty Pharmacy|September 26, 2017
Optimization of Medication Use at Accountable Care OrganizationsChrisanne Wilks, Erik Krisle, Kimberly Westrich, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2022
What might have happened: the impact of interrupting entry of innovative drugs on disease outcomes in the United StatesWilliam Herring, Michael Ciarametaro, Josephine Mauskopf, et al.
Pageof 3